OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
April 03, 2022
Collaboration and new tools aid efforts to implement new processing technologies for small-molecule drug product manufacturing.
January 03, 2022
A new focus on speed to market creates challenges for facility design and construction.
November 11, 2021
Hovione will invest $170 million in new capacity and capabilities in Portugal, Ireland, and New Jersey
September 22, 2021
Lonza’s investment in its Stein and Basel facilities in Switzerland aims to expand its overall drug product development and manufacturing services.
September 16, 2021
The COVID-19 pandemic has further impacted ongoing drug shortage issues; essential action is needed to avoid repeating previous mistakes.
August 31, 2021
USAntibiotics will serve as the sole American-based provider of amoxicillin and amoxil clavulanate.
August 18, 2021
The Cleveland, Ohio facility will produce critical anti-infective drug products for US hospitals.
August 17, 2021
Syngene’s additions include a new microbial facility and an expanded mammalian facility.
August 13, 2021
Almac Sciences has signed a manufacturing agreement with Pila Pharma for the production of the API XEN-D0501.
Recro acquires CDMO IRISYS, establishing a bi-coastal presence in the US.